Report Thumbnail
Product Code LP091190946HYZ
Published Date 2023/1/12
LP Information
English99 PagesGlobal

Global Phenylketonuria (PKU) Market Growth 2023-2029 ‐ ConsumerGoods_Retail Market


Report Thumbnail
Product Code LP091190946HYZ◆The Jan 2026 edition is also likely available. We will check with the publisher immediately.
Published Date 2023/1/12
LP Information
English 99 PagesGlobal

Global Phenylketonuria (PKU) Market Growth 2023-2029 ‐ ConsumerGoods_Retail Market


Abstract

Summary

This report studies the Phenylketonuria (PKU) market. Phenylketonuria (PKU) is an inborn error of metabolism that results in decreased metabolism of the amino acid phenylalanine. Untreated PKU can lead to intellectual disability, seizures, behavioral problems, and mental disorder. It may also result in a musty smell and lighter skin. Babies born to mothers who have poorly treated PKU may have heart problems, a small head, and low birth weight. This report mainly focuses on the treatment for PKU. LPI (LP Information)' newest research report, the “Phenylketonuria (PKU) Industry Forecast” looks at past sales and reviews total world Phenylketonuria (PKU) sales in 2022, providing a comprehensive analysis by region and market sector of projected Phenylketonuria (PKU) sales for 2023 through 2029. With Phenylketonuria (PKU) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Phenylketonuria (PKU) industry. This Insight Report provides a comprehensive analysis of the global Phenylketonuria (PKU) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Phenylketonuria (PKU) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Phenylketonuria (PKU) market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Phenylketonuria (PKU) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Phenylketonuria (PKU). The global Phenylketonuria (PKU) market size is projected to grow from US$ 1305 million in 2022 to US$ 2638.6 million in 2029; it is expected to grow at a CAGR of 2638.6 from 2023 to 2029. In the global Phenylketonuria (PKU) market, the main companies are Biomarin, Mead Johnson, Dr. Schär and Abbott, with a market share of more than 50%. The main regions are North America and Europe, with a market share of more than 70%. Supplements have the largest share of the Phenylketonuria (PKU) market, exceeding 50%. The application scenarios of Phenylketonuria (PKU) are mainly concentrated on Household, with a market share of approximately 70%. This report presents a comprehensive overview, market shares, and growth opportunities of Phenylketonuria (PKU) market by product type, application, key manufacturers and key regions and countries. Market Segmentation: Segmentation by type Medications Supplements Others Segmentation by application Household Hospital This report also splits the market by region: Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration. Biomarin Mead Johnson Abbott Nutricia Dr. Schär Vitaflo Cambrooke PKU Perspectives Firstplay Dietary Key Questions Addressed in this Report What is the 10-year outlook for the global Phenylketonuria (PKU) market? What factors are driving Phenylketonuria (PKU) market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Phenylketonuria (PKU) market opportunities vary by end market size? How does Phenylketonuria (PKU) break out type, application? What are the influences of COVID-19 and Russia-Ukraine war?

Table of Contents

  • 1 Scope of the Report

    • 1.1 Market Introduction
    • 1.2 Years Considered
    • 1.3 Research Objectives
    • 1.4 Market Research Methodology
    • 1.5 Research Process and Data Source
    • 1.6 Economic Indicators
    • 1.7 Currency Considered
    • 1.8 Market Estimation Caveats

  • 2 Executive Summary

    • 2.1 World Market Overview
      • 2.1.1 Global Phenylketonuria (PKU) Annual Sales 2018-2029
      • 2.1.2 World Current & Future Analysis for Phenylketonuria (PKU) by Geographic Region, 2018, 2022 & 2029
      • 2.1.3 World Current & Future Analysis for Phenylketonuria (PKU) by Country/Region, 2018, 2022 & 2029
    • 2.2 Phenylketonuria (PKU) Segment by Type
      • 2.2.1 Medications
      • 2.2.2 Supplements
      • 2.2.3 Others
    • 2.3 Phenylketonuria (PKU) Sales by Type
      • 2.3.1 Global Phenylketonuria (PKU) Sales Market Share by Type (2018-2023)
      • 2.3.2 Global Phenylketonuria (PKU) Revenue and Market Share by Type (2018-2023)
      • 2.3.3 Global Phenylketonuria (PKU) Sale Price by Type (2018-2023)
    • 2.4 Phenylketonuria (PKU) Segment by Application
      • 2.4.1 Household
      • 2.4.2 Hospital
    • 2.5 Phenylketonuria (PKU) Sales by Application
      • 2.5.1 Global Phenylketonuria (PKU) Sale Market Share by Application (2018-2023)
      • 2.5.2 Global Phenylketonuria (PKU) Revenue and Market Share by Application (2018-2023)
      • 2.5.3 Global Phenylketonuria (PKU) Sale Price by Application (2018-2023)

  • 3 Global Phenylketonuria (PKU) by Company

    • 3.1 Global Phenylketonuria (PKU) Breakdown Data by Company
      • 3.1.1 Global Phenylketonuria (PKU) Annual Sales by Company (2018-2023)
      • 3.1.2 Global Phenylketonuria (PKU) Sales Market Share by Company (2018-2023)
    • 3.2 Global Phenylketonuria (PKU) Annual Revenue by Company (2018-2023)
      • 3.2.1 Global Phenylketonuria (PKU) Revenue by Company (2018-2023)
      • 3.2.2 Global Phenylketonuria (PKU) Revenue Market Share by Company (2018-2023)
    • 3.3 Global Phenylketonuria (PKU) Sale Price by Company
    • 3.4 Key Manufacturers Phenylketonuria (PKU) Producing Area Distribution, Sales Area, Product Type
      • 3.4.1 Key Manufacturers Phenylketonuria (PKU) Product Location Distribution
      • 3.4.2 Players Phenylketonuria (PKU) Products Offered
    • 3.5 Market Concentration Rate Analysis
      • 3.5.1 Competition Landscape Analysis
      • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
    • 3.6 New Products and Potential Entrants
    • 3.7 Mergers & Acquisitions, Expansion

  • 4 World Historic Review for Phenylketonuria (PKU) by Geographic Region

    • 4.1 World Historic Phenylketonuria (PKU) Market Size by Geographic Region (2018-2023)
      • 4.1.1 Global Phenylketonuria (PKU) Annual Sales by Geographic Region (2018-2023)
      • 4.1.2 Global Phenylketonuria (PKU) Annual Revenue by Geographic Region (2018-2023)
    • 4.2 World Historic Phenylketonuria (PKU) Market Size by Country/Region (2018-2023)
      • 4.2.1 Global Phenylketonuria (PKU) Annual Sales by Country/Region (2018-2023)
      • 4.2.2 Global Phenylketonuria (PKU) Annual Revenue by Country/Region (2018-2023)
    • 4.3 Americas Phenylketonuria (PKU) Sales Growth
    • 4.4 APAC Phenylketonuria (PKU) Sales Growth
    • 4.5 Europe Phenylketonuria (PKU) Sales Growth
    • 4.6 Middle East & Africa Phenylketonuria (PKU) Sales Growth

  • 5 Americas

    • 5.1 Americas Phenylketonuria (PKU) Sales by Country
      • 5.1.1 Americas Phenylketonuria (PKU) Sales by Country (2018-2023)
      • 5.1.2 Americas Phenylketonuria (PKU) Revenue by Country (2018-2023)
    • 5.2 Americas Phenylketonuria (PKU) Sales by Type
    • 5.3 Americas Phenylketonuria (PKU) Sales by Application
    • 5.4 United States
    • 5.5 Canada
    • 5.6 Mexico
    • 5.7 Brazil

  • 6 APAC

    • 6.1 APAC Phenylketonuria (PKU) Sales by Region
      • 6.1.1 APAC Phenylketonuria (PKU) Sales by Region (2018-2023)
      • 6.1.2 APAC Phenylketonuria (PKU) Revenue by Region (2018-2023)
    • 6.2 APAC Phenylketonuria (PKU) Sales by Type
    • 6.3 APAC Phenylketonuria (PKU) Sales by Application
    • 6.4 China
    • 6.5 Japan
    • 6.6 South Korea
    • 6.7 Southeast Asia
    • 6.8 India
    • 6.9 Australia
    • 6.10 China Taiwan

  • 7 Europe

    • 7.1 Europe Phenylketonuria (PKU) by Country
      • 7.1.1 Europe Phenylketonuria (PKU) Sales by Country (2018-2023)
      • 7.1.2 Europe Phenylketonuria (PKU) Revenue by Country (2018-2023)
    • 7.2 Europe Phenylketonuria (PKU) Sales by Type
    • 7.3 Europe Phenylketonuria (PKU) Sales by Application
    • 7.4 Germany
    • 7.5 France
    • 7.6 UK
    • 7.7 Italy
    • 7.8 Russia

  • 8 Middle East & Africa

    • 8.1 Middle East & Africa Phenylketonuria (PKU) by Country
      • 8.1.1 Middle East & Africa Phenylketonuria (PKU) Sales by Country (2018-2023)
      • 8.1.2 Middle East & Africa Phenylketonuria (PKU) Revenue by Country (2018-2023)
    • 8.2 Middle East & Africa Phenylketonuria (PKU) Sales by Type
    • 8.3 Middle East & Africa Phenylketonuria (PKU) Sales by Application
    • 8.4 Egypt
    • 8.5 South Africa
    • 8.6 Israel
    • 8.7 Turkey
    • 8.8 GCC Countries

  • 9 Market Drivers, Challenges and Trends

    • 9.1 Market Drivers & Growth Opportunities
    • 9.2 Market Challenges & Risks
    • 9.3 Industry Trends

  • 10 Manufacturing Cost Structure Analysis

    • 10.1 Raw Material and Suppliers
    • 10.2 Manufacturing Cost Structure Analysis of Phenylketonuria (PKU)
    • 10.3 Manufacturing Process Analysis of Phenylketonuria (PKU)
    • 10.4 Industry Chain Structure of Phenylketonuria (PKU)

  • 11 Marketing, Distributors and Customer

    • 11.1 Sales Channel
      • 11.1.1 Direct Channels
      • 11.1.2 Indirect Channels
    • 11.2 Phenylketonuria (PKU) Distributors
    • 11.3 Phenylketonuria (PKU) Customer

  • 12 World Forecast Review for Phenylketonuria (PKU) by Geographic Region

    • 12.1 Global Phenylketonuria (PKU) Market Size Forecast by Region
      • 12.1.1 Global Phenylketonuria (PKU) Forecast by Region (2024-2029)
      • 12.1.2 Global Phenylketonuria (PKU) Annual Revenue Forecast by Region (2024-2029)
    • 12.2 Americas Forecast by Country
    • 12.3 APAC Forecast by Region
    • 12.4 Europe Forecast by Country
    • 12.5 Middle East & Africa Forecast by Country
    • 12.6 Global Phenylketonuria (PKU) Forecast by Type
    • 12.7 Global Phenylketonuria (PKU) Forecast by Application

  • 13 Key Players Analysis

    • 13.1 Biomarin
      • 13.1.1 Biomarin Company Information
      • 13.1.2 Biomarin Phenylketonuria (PKU) Product Portfolios and Specifications
      • 13.1.3 Biomarin Phenylketonuria (PKU) Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.1.4 Biomarin Main Business Overview
      • 13.1.5 Biomarin Latest Developments
    • 13.2 Mead Johnson
      • 13.2.1 Mead Johnson Company Information
      • 13.2.2 Mead Johnson Phenylketonuria (PKU) Product Portfolios and Specifications
      • 13.2.3 Mead Johnson Phenylketonuria (PKU) Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.2.4 Mead Johnson Main Business Overview
      • 13.2.5 Mead Johnson Latest Developments
    • 13.3 Abbott
      • 13.3.1 Abbott Company Information
      • 13.3.2 Abbott Phenylketonuria (PKU) Product Portfolios and Specifications
      • 13.3.3 Abbott Phenylketonuria (PKU) Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.3.4 Abbott Main Business Overview
      • 13.3.5 Abbott Latest Developments
    • 13.4 Nutricia
      • 13.4.1 Nutricia Company Information
      • 13.4.2 Nutricia Phenylketonuria (PKU) Product Portfolios and Specifications
      • 13.4.3 Nutricia Phenylketonuria (PKU) Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.4.4 Nutricia Main Business Overview
      • 13.4.5 Nutricia Latest Developments
    • 13.5 Dr. Schär
      • 13.5.1 Dr. Schär Company Information
      • 13.5.2 Dr. Schär Phenylketonuria (PKU) Product Portfolios and Specifications
      • 13.5.3 Dr. Schär Phenylketonuria (PKU) Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.5.4 Dr. Schär Main Business Overview
      • 13.5.5 Dr. Schär Latest Developments
    • 13.6 Vitaflo
      • 13.6.1 Vitaflo Company Information
      • 13.6.2 Vitaflo Phenylketonuria (PKU) Product Portfolios and Specifications
      • 13.6.3 Vitaflo Phenylketonuria (PKU) Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.6.4 Vitaflo Main Business Overview
      • 13.6.5 Vitaflo Latest Developments
    • 13.7 Cambrooke
      • 13.7.1 Cambrooke Company Information
      • 13.7.2 Cambrooke Phenylketonuria (PKU) Product Portfolios and Specifications
      • 13.7.3 Cambrooke Phenylketonuria (PKU) Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.7.4 Cambrooke Main Business Overview
      • 13.7.5 Cambrooke Latest Developments
    • 13.8 PKU Perspectives
      • 13.8.1 PKU Perspectives Company Information
      • 13.8.2 PKU Perspectives Phenylketonuria (PKU) Product Portfolios and Specifications
      • 13.8.3 PKU Perspectives Phenylketonuria (PKU) Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.8.4 PKU Perspectives Main Business Overview
      • 13.8.5 PKU Perspectives Latest Developments
    • 13.9 Firstplay Dietary
      • 13.9.1 Firstplay Dietary Company Information
      • 13.9.2 Firstplay Dietary Phenylketonuria (PKU) Product Portfolios and Specifications
      • 13.9.3 Firstplay Dietary Phenylketonuria (PKU) Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.9.4 Firstplay Dietary Main Business Overview
      • 13.9.5 Firstplay Dietary Latest Developments

  • 14 Research Findings and Conclusion

USD 3,660 or Partial Purchase
*Prices are subject to change by the publisher.
© 2026 ShareFair Inc.